|
|
| | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid Basic information |
| Product Name: | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | | Synonyms: | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid;6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)-;5,7-dichloro-1,2,3,4-tetrahydro-2-tritylisoquinoline-6-carboxylic acid;5,7-Dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)-6-isoquinolinecarboxylic Acid;1194550-56-5 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | | CAS: | 1194550-56-5 | | MF: | C29H23Cl2NO2 | | MW: | 488.4 | | EINECS: | | | Product Categories: | | | Mol File: | 1194550-56-5.mol |  |
| | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid Chemical Properties |
| Boiling point | 598.2±50.0 °C(Predicted) | | density | 1.323±0.06 g/cm3(Predicted) | | pka | 1.40±0.20(Predicted) |
| | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid Usage And Synthesis |
| Uses | 5,7-Dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)-6-isoquinolinecarboxylic Acid, can be sued in the preparation of novel series of compounds which has been found to be a potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for treating dry eye. |
| | 5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid Preparation Products And Raw materials |
| Preparation Products | L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)-->5,7-Dichloro-1,2,3,4-Tetrahydroisoquinoline-6-Carboxylic Acid Hydrochloride |
|